Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

Retinopathy of Prematurity (ROP) –Management of an Infant Born at 30 Weeks Gestational Age in a Rural Area

December 12, 2023

FEATURING: Jeffrey Dunn, PharmD, MBA, Edward H. Wood, MD

← PayerTalkCE™Presents: Impact of An Aging US Population on Retinal Diseases   Risk of Retinal Vein Occlusion (RVO) –52-Year-Old Male with a History of Poor Adherence to Hypertension and Dyslipidemia Therapy →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now